Globe Life Inc. (NYSE:GL – Get Free Report) EVP Michael Clay Majors sold 37,000 shares of the business’s stock in a transaction on Wednesday, July 29th. The stock was sold at an average price of $178.64, for a total transaction of $6,609,680.00. Following the completion of the transaction, the executive vice president owned 53,518 shares of the company’s stock, valued at approximately $9,560,455.52. This trade represents a 40.88% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Globe Life Stock Up 1.7%
Shares of NYSE GL opened at $182.65 on Friday. The stock has a market cap of $14.18 billion, a P/E ratio of 12.13 and a beta of 0.47. The business’s fifty day simple moving average is $171.01 and its 200-day simple moving average is $154.07. Globe Life Inc. has a 12-month low of $127.85 and a 12-month high of $191.55. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38.
Globe Life (NYSE:GL – Get Free Report) last issued its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing the consensus estimate of $3.67 by ($0.06). The company had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Globe Life had a return on equity of 20.73% and a net margin of 19.58%.Globe Life’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter last year, the company earned $3.05 EPS. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, equities analysts predict that Globe Life Inc. will post 15.7 EPS for the current fiscal year.
Institutional Trading of Globe Life
Analyst Ratings Changes
Several brokerages recently weighed in on GL. Keefe, Bruyette & Woods reduced their target price on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a report on Friday, July 24th. TD Cowen boosted their price target on shares of Globe Life from $215.00 to $225.00 and gave the stock a “buy” rating in a report on Wednesday, July 22nd. Piper Sandler increased their price objective on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research report on Wednesday, July 15th. JPMorgan Chase & Co. raised their price objective on shares of Globe Life from $181.00 to $201.00 and gave the company an “overweight” rating in a report on Tuesday, July 21st. Finally, Jefferies Financial Group boosted their target price on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research note on Friday, July 10th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $191.67.
Check Out Our Latest Stock Analysis on Globe Life
Globe Life Company Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Featured Articles
- Five stocks we like better than Globe Life
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
